Therapeutic use of zoster-immune plasma: A report of 8 cases.
Varicella and herpes zoster can be serious or even fatal diseases in immunocompromised patients. However, they can be prevented or markedly attenuated by the administration of zoster-immune globulin (ZIG) or zoster-immune plasma (ZIP), but there is no established treatment once these disorders have occurred. Eight such patients were treated with ZIP, with promising results.
D000328:Adult; D002644:Chickenpox / Q000517:prevention & control*; D002648:Child; D005260:Female; D006562:Herpes Zoster / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D008875:Middle Aged; D012306:Risk
D007136:Immunoglobulins